ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BYSI BeyondSpring Inc

2.25
0.0899 (4.16%)
May 03 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 45,518
Bid Price 2.21
Ask Price 2.40
News (1)
Day High 2.32

Low
0.6534

52 Week Range

High
4.00

Day Low 2.18
Share Name Share Symbol Market Stock Type
BeyondSpring Inc BYSI NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0899 4.16% 2.25 17:00:00
Open Price Low Price High Price Close Price Previous Close
2.18 2.18 2.32 2.25 2.1601
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
258 45,518 US$ 2.26 US$ 102,898 - 0.6534 - 4.00
Last Trade Type Quantity Price Currency
18:58:05 2 US$ 2.2504 USD

BeyondSpring Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
89.13M 38.92M - 1.35M -33.28M -0.86 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

BeyondSpring News

Date Time Source News Article
5/03/202406:00GlobeNewswire Inc.BeyondSpring To Host Virtual R&D Day to Discuss New..
4/29/202416:30GlobeNewswire Inc.BeyondSpring Provides Business Update and Reports Year End..
3/25/202406:00GlobeNewswire Inc.BeyondSpring Announces First Patient Dosed with..
2/26/202407:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/26/202407:00GlobeNewswire Inc.BeyondSpring Regains Compliance with Nasdaq Minimum Bid..
2/14/202415:30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
2/02/202415:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/16/202415:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/10/202414:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/10/202414:00GlobeNewswire Inc.BeyondSpring Receives Nasdaq Delinquency Notice Regarding..
12/18/202315:31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/18/202315:30GlobeNewswire Inc.BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BYSI Message Board. Create One! See More Posts on BYSI Message Board See More Message Board Posts

Historical BYSI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.362.381.73432.1224,038-0.11-4.66%
1 Month2.70672.9781.73432.1971,046-0.4567-16.87%
3 Months1.144.001.052.81236,3511.1197.37%
6 Months0.93674.000.77772.50132,3051.31140.20%
1 Year0.96094.000.65342.0198,2631.29134.16%
3 Years10.9033.000.54213.34669,977-8.65-79.36%
5 Years14.7233.000.54213.30457,655-12.47-84.71%

BeyondSpring Description

BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin has increased the survival of neutrophils, a type of white blood cell important in the prevention of bacterial infections. The Company has a scalable business model integrating clinical resources in the United States and China.

Your Recent History

Delayed Upgrade Clock